key: cord-0737745-hx6n03ri
authors: Danino, Dana; Ben-Shimol, Shalom; Van Der Beek, Bart Adriaan; Givon-Lavi, Noga; Avni, Yonat Shemer; Greenberg, David; Weinberger, Daniel M; Dagan, Ron
title: Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study
date: 2021-12-14
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab1014
sha: 40622275cf5fef54e400a6d673628a55d0f9d907
doc_id: 737745
cord_uid: hx6n03ri

BACKGROUND: The incidence of invasive pneumococcal disease (IPD) declined during the COVID-19 pandemic. Previous studies hypothesized that this was due to reduced pneumococcal transmission resulting from non-pharmaceutical interventions. We used multiple ongoing cohort surveillance projects in children <5 years to test this hypothesis. METHODS: The first SARS-CoV-2 cases were detected in February-2020, resulting in a full lockdown, followed by several partial restrictions. Data from ongoing surveillance projects captured the incidence dynamics of community-acquired alveolar pneumonia (CAAP), non-alveolar lower respiratory infections necessitating chest X-rays (NA-LRI), nasopharyngeal pneumococcal carriage in non-respiratory visits, nasopharyngeal respiratory virus detection (by PCR), and nationwide invasive pneumococcal disease (IPD). Monthly rates (January-2020 through February-2021 vs. mean monthly rates 2016-2019 [expected rates]) adjusted for age and ethnicity, were compared. RESULTS: CAAP and bacteremic pneumococcal pneumonia were strongly reduced (incidence rate ratios, [IRRs] .07 and .19, respectively); NA-LRI and non-pneumonia IPD were also reduced, with a lesser magnitude (IRRs, .46 and .42, respectively). In contrast, pneumococcal carriage prevalence was only slightly reduced, and density of colonization and pneumococcal serotype distributions were similar to previous years. The decline in pneumococcus-associated disease was temporally associated with a full suppression of RSV, influenza viruses, and hMPV, often implicated as co-pathogens with pneumococcus. In contrast, adenovirus, rhinovirus, and parainfluenza activities were within or above expected levels. CONCLUSIONS: Reductions in pneumococcal and pneumococcus-associated diseases occurring during the COVID-19 pandemic in Israel were not predominantly related to reduced pneumococcal carriage and density, but were strongly associated with the disappearance of specific respiratory viruses.

Streptococcus pneumoniae (pneumococcus) is a leading cause of acute respiratory and invasive infections in all ages [1] . Pneumococcal disease rates are influenced by the frequency of pneumococcal exposure (i.e., nasopharyngeal carriage prevalence among healthy children) and host susceptibility. Epidemiological, clinical, and experimental evidence suggests that certain viruses can increase the susceptibility to pneumococcal disease [1] [2] [3] . Since SARS-CoV-2 is a respiratory virus, concerns were raised that COVID-19 could increase susceptibility to pneumonia and invasive pneumococcal diseases (IPD). However, early reports during the pandemic demonstrated reduced IPD rates [4] , and co-infections of these two pathogens were infrequent [5] . At the same time, non-pharmacological interventions (NPIs) such as social distancing and travel restrictions were associated with an unexpected global suppression of the activity of several seasonal respiratory viruses, often implicated as co-pathogens with pneumococcus. These include respiratory syncytial virus (RSV), influenza viruses, and human metapneumovirus (hMPV) [6, 7] . We hypothesized that the reduction in pneumococcal disease in children observed during the COVID-19 pandemic was due mainly to the reduction in the incidence of these seasonal respiratory viruses rather than to reductions in transmission of pneumococcus.

We took advantage of multiple ongoing prospective pediatric cohort surveillance projects in our region to assess the dynamics of various clinical presentations associated with pneumococcus during the COVID-19 pandemic period (January 2020 through February 2021). The pneumococcal disease rates during the pandemic were compared to those during 2016-2019 and to common seasonal respiratory virus dynamics. Uniquely, our data included information on clinical pneumococcal diseases, pneumococcal carriage among healthy A c c e p t e d M a n u s c r i p t 6 children, and the activity of specific respiratory viruses. These data provide an opportunity to understand the factors influencing the incidence of pneumococcal disease in children.

The Soroka University Medical Center (SUMC) is the only hospital in the Negev, southern Israel, providing primary health services to the entire population of the region. Over 95% of the children living in the region are served by the SUMC, enabling incidence calculations.

Two ethnic populations reside in southern Israel: The Bedouin population, with infectious diseases epidemiology similar to lower-middle income countries; and the Jewish population whose epidemiology resembles higher-income Western countries. Higher rates of respiratory and invasive disease, and pneumococcal carriage were reported among Bedouin than among Jewish children [8] . In 2020, there were ~97,400 children <5 years in the Negev; ~50% were

Pneumococcal conjugate vaccines (PCVs) were introduced to the National Immunization Plan in 2009 (PCV7) and 2010 (PCV13); since 2013 ~90% of children have received three doses [10] .

The first COVID-19 case occurred in Israel on February 21, 2020. Three official national lockdown periods, with variable degrees of stringency, were implemented thereafter respectively, reaching >8,000 daily new cases by January 2021. With increasing vaccination coverage, the rates declined towards mid-February.

The study population for pneumonia and virological testing comprised all cohorts of children <5 years living in our region January 2016 -February 2021. For IPD, we included all children <5 years nationwide. For pneumococcal carriage, we included children <3 years in our region. Our data were derived from multiple ongoing, prospective long-standing cohort surveillance programs. Monthly incidence or prevalence rates during 2020-2021 were compared to mean monthly rates during 2016-2019. The total numbers for each database and the comparison of demographic characteristics, during 2016-2019 and January 2020-February 2021 are presented in 

This is an ongoing, nationwide prospective, active surveillance, initiated in 1989. All IPD cases in children <5 years were reported monthly by local investigators in all 27 medical centers where blood and CSF cultures were obtained, accounting for >95% all IPD cases. A bacteremic pneumonia episode was defined as an episode diagnosed as pneumonia by the treating physician during which S. pneumoniae was isolated from blood [14] . A non-pneumonia IPD episode was defined as an IPD episode excluding bacteremic pneumonia. assessed by semi-quantitative methodology [15] . b) Healthy children: Since 2011, nasopharyngeal cultures have been obtained from healthy children <3 years, presenting for vaccination [16] . The detailed methodology was previously described [10] . 5 M a n u s c r i p t 9 6) All pediatric PER visits and hospitalizations: Data were collected from the SUMC computerized records. 7) Hospital visits for all-cause trauma: PER visits with trauma diagnosis were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) discharge codes.

All the above projects, as well as the overall current study were approved by the SUMC Ethics Committee.

Demographical characteristics were compared between the pre-COVID-19 years (2016-2019) and the COVID-19 period (2020-2021) using the Pearson χ2 test or Student's t-test, as appropriate. Monthly incidence rates for all end-points were calculated by age (<2, 2-4 years) and ethnicity (Bedouin, Jewish). The monthly proportions of positive pneumococcal nasopharyngeal cultures were calculated out of all samples for children <1 and 2-3 years, except during April-May 2020 (the strict lockdown) due to disruptions in sample collection.

No difference in the age distribution of the population <5 was observed during the study years. Rate ratios of incidences and proportions were calculated to compare COVID-19 and pre-COVID-19 periods. All rate ratios were adjusted for ethnicity and age using the Cochran-Mantel-Haenszel method.

The statistical significance threshold was P < .05. Data were analyzed using R 4.0.2 [18] .

A c c e p t e d M a n u s c r i p t 10

The first COVID-19 case was identified on February 21, 2020. All NPIs that followed, along with the dynamics of new daily nationwide COVID-19 cases, are described in 

During October 2020 through February 2021, there was a marked reduction in IPD rates vs. Figure   2 ). However, while bacteremic pneumonia declined by 81% compared to the pre-COVID period, non-pneumonia IPD declined only by 42% (Figure 1A-D) .

Overall LRI rates were reduced during fall and winter 2020-2021 ( Tables 2, 5 ). However, the variations between seasons were of a lesser magnitude compared to CAAP. As observed for CAAP, during the first quarter of 2020 the dynamics were not affected, and the second quarter was affected mainly by the first strict lockdown. However, unlike CAAP rates, NA-LRIs rates increased again following the first lockdown to reach the expected seasonal rate in July-September. The reduction during October 2020 to February 2021 vs. the rates in 2016-2019 was only half compared to that of CAAP (46%, 95% CI 43-50%; vs. 93%, 95% CI 90-95%, respectively).

During 2016-2019, the mean proportion of children <3 years old carrying pneumococcus was 44.3±1.9%, ranging from 33.8% (August) to 53.8% (December) (Figure 2 ; Supplementary Table 6 ). Nasopharyngeal testing was temporarily interrupted during the months April-May 2020. Although carriage rates were somewhat reduced in October-December 2020, the rates during January-February 2021 were not significantly different than those in previous years Table 6 ). . Furthermore, using a semi-quantitative method, the mean bacterial density was within the ranges of the previous years. Additionally, no notable difference in pneumococcal serotype distribution between the COVID-19 and the pre-COVID period was seen (Supplementary Table 7 

A c c e p t e d M a n u s c r i p t 12

The detection of respiratory viruses in children during the four years preceding 2020 showed typical dynamics of temperate zone seasonality [19] (Figures 3, 4; Supplementary Table 8 ).

Apart from rhinovirus, which was common throughout the year, the most prevalent virus was RSV. Fall to early-spring seasonality was seen for RSV, influenza viruses, and hMPV; adenovirus was perennial with some decrease in the summer months; parainfluenza was lower in winter and spring compared to summer and fall. From January through March 2020, the detection of respiratory viruses was within that expected for the season. During the first 

Throughout the study duration, excluding the first strict lockdown period, the dynamics of pneumococcus-associated disease closely followed those of RSV, influenza viruses, and hMPV. This was most striking with bacteremic pneumonia (Supplementary Figure 4) and A c c e p t e d M a n u s c r i p t 13 CAAP. For NA-LRI and non-pneumonia IPD, the association was less apparent. However, the peak that would typically occur during winter, coinciding with epidemics of RSV, influenza viruses, and hMPV did not occur (Supplementary Figure 5) .

We evaluated trends in hospital visits for trauma, since they are essentially independent of respiratory infections, to examine whether some of the observed reductions in the reporting of LRIs will be related to lower detection rates during the COVID-19 epidemic (Supplementary Figure 6) . As expected, trauma visits peaked in the warm months, in contrast to the non-trauma visits, peaking during fall and winter. For both, a reduction during the first strict lockdown period was seen, but the trauma visit returned to close-to-normal rates, while the overall visits failed to show the expected fall and winter spike.

This prospective cohort study demonstrates a marked reduction of hospital visit rates in southern Israel for both LRI and pneumococcal disease in children <5 year old during winter 2020-2021, coinciding with the peak of the COVID-19 pandemic. This reduction was closely associated with an extreme suppression of the circulation of specific respiratory viruses:

RSV, influenza viruses, and hMPV. The most dramatic reductions were seen in CAAP and bacteremic pneumonia, but NA-LRI and non-pneumonia IPD were also reduced. In contrast, during the same period, pneumococcal nasopharyngeal carriage prevalence was only slightly reduced, and density of colonization and pneumococcal serotype distribution were similar to those in previous years. This was a surprising finding because carriage is a prerequisite for pneumococcal disease.

A c c e p t e d M a n u s c r i p t 14 In most published reports, NPIs were suggested to be responsible for reduced pneumococcal carriage, circulation, and transmission, resulting in reduced pneumococcal disease [20] [21] [22] [23] [24] [25] .

Our findings lead to the hypothesis that the reduction in pneumococcus-associated disease during fall-winter 2020-2021 resulted mainly from the complete suppression of specific respiratory viruses rather than reduced transmissibility or serotype selection of S. pneumoniae in the community. These viruses, especially RSV and influenza are epidemiologically associated with both increased pneumococcal bacteremic pneumonia and non-bacteremic CAAP [14, 26] . Furthermore, the most frequently detected virus during IPD and alveolar pneumonia is RSV, followed by influenza viruses and hMPV [3, 27] . The strong association of these viruses with pneumonia might explain why the reduction during fall-winter 2020-2021 was of a higher magnitude in the case of bacteremic pneumonia and CAAP than in nonpneumonia IPD and NA-LRIs.

While, by definition, S. pneumoniae is the causative agent for IPD, the extent of pneumococcal involvement in CAAP and NA-LRI is still not fully clarified. This cannot be directly answered, since often pathogens cannot be isolated in young children, and detection of bacteria or viruses in the respiratory tract does not necessarily imply their causative role.

However, measuring pneumococcal PCV impact on CAAP and LRI (the vaccine probe approach) provides a powerful tool for inference on the likely causative role of S. pneumoniae in these clinical outcomes [28] . Studies from Israel and elsewhere, have demonstrated a ~50% reduction in CAAP in young children following PCV implementation [13, 29] , thus strongly suggesting an extensive causative role of S. pneumoniae in CAAP during the pre-PCV era.

Our NA-LRI cases were severe enough to warrant a chest radiography, but per definition, those with CAAP were excluded. Studies have shown that in such cases, a rate reduction of A c c e p t e d M a n u s c r i p t 15 ≥25% was observed in young children post PCV implementation, including a 34% reduction in our region [13] . Using a similar logic as per CAAP, it is plausible that vaccine-serotype pneumococci also played an important role in NA-LRI, although of a lesser magnitude. The similarity in dynamics between CAAP and IPD, in particular bacteremic pneumonia is therefore not surprising.

Animal and human models have demonstrated that viral infections predispose not only to post-viral pneumococcal diseases, but frequently true respiratory viral-bacterial co-infections [1] . This explains why PCVs reduced hospitalization for viral infections, including viral pneumonia [3, 30] . Multiple mechanisms by which viruses enhance virulence or invasiveness of S. pneumoniae were described, mainly with RSV and influenza viruses [31, 32] . It is therefore not surprising that the seasonality of IPD and pneumonia overlap, especially regarding CAAP and bacteremic pneumonia [14] . It is also plausible that the suppression of CAAP and IPD (and bacteremic pneumonia in particular) is deeper than that of NA-LRI diseases for which a lower causative role of S. pneumoniae is assumed.

The dynamics of NA-LRIs were similar, but not identical to those of CAAP. After the initial rate reduction during the strict first lockdown, the rates returned to those seasonally expected and observed in 2016-2019. Despite this, the expected late-fall and winter increases did not occur, presumably due to the absence of RSV, influenza viruses, and hMPV. Yet, the rates were not reduced as much as those of CAAP, but rather showed the same magnitude as those in summer. The NA-LRI pattern in 2020-21 suggests that viruses such as parainfluenza and adenovirus, and potentially also rhinovirus and others could play a relative greater role for this entity than for CAAP.

It is not clear why adenovirus, and rhinovirus rates were not significantly decreased during 2020-2021, in contrast to RSV, hMPV, and influenza virus. While adenovirus can be carried A c c e p t e d M a n u s c r i p t 16 for long periods, rhinoviruses are carried only for short periods [33, 34] , and thus its high prevalence suggests frequent infections.

Multiple reports showed off-season re-emergence of RSV and hMPV worldwide, mostly in spring and summer 2021. In Germany, re-emergence of IPD was speculated to be linked to viral re-emergence. In Israel, the Ministry of Health reported re-emergence of hMPV and RSV in spring and summer with parallel re-emergence of hospital visits for pneumonia in children <5 years [35] . Preliminary results by our study group suggest co-re-emergence of RSV, hMPV, and pneumococcal-associated diseases (Data not shown). Further detailed analysis is planned.

The main strength of our study is its prospective conduct, using multiple ongoing cohort surveillance programs in the same population, enabling to compare dynamics during the pandemic to those during previous years, on the one hand, and different outcomes, on the other, with appropriate adjustments for time, age and ethnicity. The main weakness of the current study was the inability to determine with certainty the causative agents in the CAAP and NA-LRI cases, a difficulty inherent to all studies on LRI in infants and young children.

An additional weakness was that we did not attempt to diagnose all potential viral pathogens including non-COVID-19 corona viruses.

In conclusion, the reductions in pneumococcal disease in children during the COVID-19 pandemic were not predominantly related to reduced or modified pneumococcal carriage, 

The study was partially supported by Pfizer, Inc. 

Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination

Evidence from multiplex molecular assays for complex multipathogen interactions in acute respiratory infections

Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

The Impact of social distancing for SARS-CoV-2 on respiratory syncytial virus and influenza burden

Shifting patterns of respiratory virus activity following social distancing measures for COVID-19 in South Korea

Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines

Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel

COVID-19 Data Repository of the Israeli Ministry of Health

Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential

Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children

Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era

PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children

Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines

Identification of respiratory viruses in adults: nasopharyngeal versus oropharyngeal sampling

R: A language and environment for statistical computing. R Foundation for Statistical Computing

Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis

Telemedicine and Health Disparities During COVID-19

Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis

Indirect effects of the COVID-19 pandemic on paediatric healthcare use and severe disease: a retrospective national cohort study

Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?

Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021

Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implemenation of non-pharmaceutical interventions during COVID-19 pandemic

Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity

Nasopharyngeal Pneumococcal Carriage During Childhood Community-Acquired Alveolar Pneumonia: Relationship Between Specific Serotypes and Coinfecting Viruses

Use of vaccines as probes to define disease burden

Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years

Vaccine Trialist G. A role for Streptococcus pneumoniae in virusassociated pneumonia

Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection

Insights into the interaction between influenza virus and pneumococcus

Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness

Duration of rhinovirus shedding in the upper respiratory tract in the first year of life

Report on surveillance of influezalike morbidity, weekly reports

6%) 45,637 (46.1%) 9,751 (43.3%) <.001 c Bedouin 66,105 (54.4%) 53,352 (53.9%) 12,753 (56.7%) Trauma Cases 17

5%) 7,613 (41.7%) 1,537 (35.6%) <.001 c Bedouin

A c c e p t e d M a n u s c r i p t